Peel Hunt reiterated their add rating on shares of UDG Healthcare (LON:UDG) in a report published on Wednesday.
A number of other brokerages also recently issued reports on UDG. Numis Securities reiterated a reduce rating and issued a GBX 765 ($10.74) price target on shares of UDG Healthcare in a report on Tuesday, January 30th. Libertas Partners upgraded shares of UDG Healthcare to a buy rating and set a GBX 884 ($12.41) target price on the stock in a report on Wednesday, February 7th. N+1 Singer restated a hold rating and issued a GBX 813 ($11.41) target price on shares of UDG Healthcare in a report on Wednesday, February 7th. Liberum Capital restated a hold rating and issued a GBX 884 ($12.41) target price on shares of UDG Healthcare in a report on Tuesday, January 30th. Finally, Jefferies Group restated a hold rating and issued a GBX 820 ($11.51) target price on shares of UDG Healthcare in a report on Wednesday, January 17th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company’s stock. UDG Healthcare currently has a consensus rating of Hold and an average price target of GBX 832.63 ($11.69).
Shares of LON UDG opened at GBX 882.50 ($12.39) on Wednesday. UDG Healthcare has a 52-week low of GBX 690 ($9.69) and a 52-week high of GBX 963 ($13.52).
In other news, insider Chris Corbin sold 730,000 shares of the business’s stock in a transaction dated Tuesday, March 13th. The shares were sold at an average price of GBX 870 ($12.21), for a total value of £6,351,000 ($8,914,935.43).
WARNING: “UDG Healthcare’s (UDG) Add Rating Reiterated at Peel Hunt” was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this news story on another domain, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/04/07/udg-healthcares-udg-add-rating-reiterated-at-peel-hunt.html.
About UDG Healthcare
UDG Healthcare PLC, formerly United Drug PLC, provides advisory, commercial, clinical, communications and packaging services to the healthcare industry with operations in approximately 24 countries and delivering services in over 50 countries. The Company operates across three divisions: Ashfield, which provides commercialization services for the pharmaceutical and healthcare industry and operates across two areas of activity: advisory & communications services and commercial & clinical services and provides healthcare communications, patient support, audit, advisory, medical information and event management services; Sharp, which provides contract commercial packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries and operates facilities in the United States and Europe; and Aquilant, which provides outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in the UK, Ireland and the Netherlands.
Receive News & Ratings for UDG Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UDG Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.